These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2314777)

  • 41. Teratogen update: anesthetic agents.
    Friedman JM
    Teratology; 1988 Jan; 37(1):69-77. PubMed ID: 3279563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantifying human health risks from virginiamycin used in chickens.
    Cox LA; Popken DA
    Risk Anal; 2004 Feb; 24(1):271-88. PubMed ID: 15028017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Big risks in small groups: The difference between epidemiology and counselling.
    Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy in women who have epilepsy.
    Pennell PB
    Neurol Clin; 2004 Nov; 22(4):799-820. PubMed ID: 15474768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outpatient use of cardiovascular drugs during pregnancy.
    Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National patterns of medication use during pregnancy.
    Lee E; Maneno MK; Smith L; Weiss SR; Zuckerman IH; Wutoh AK; Xue Z
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):537-45. PubMed ID: 16700083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDA board investigates Depo-Provera safety.
    Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epilepsy and pregnancy].
    Nakken KO; Johannessen SI; Henriksen O
    Tidsskr Nor Laegeforen; 1999 Sep; 119(23):3437-40. PubMed ID: 10553342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of drug-induced congenital defects.
    De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugs during pregnancy: an issue of risk classification and information to prescribers.
    Sannerstedt R; Lundborg P; Danielsson BR; Kihlström I; Alván G; Prame B; Ridley E
    Drug Saf; 1996 Feb; 14(2):69-77. PubMed ID: 8852521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The U.S. Food and Drug Adminstration (FDA) has assigned pregnancy category D to valproate.
    Peckman H
    N C Med J; 2010; 71(4):396-8. PubMed ID: 21155112
    [No Abstract]   [Full Text] [Related]  

  • 53. Teratogenic Agent Information Centre: fifteen years of counseling and pregnancy follow-up.
    Eléfant E; Boyer M; Boyer P; Galliot B; Roux C
    Teratology; 1992 Jul; 46(1):35-44. PubMed ID: 1641810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.
    Peters SL; Lind JN; Humphrey JR; Friedman JM; Honein MA; Tassinari MS; Moore CA; Mathis LL; Broussard CS
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):324-8. PubMed ID: 23359404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of semi-quantitative approaches in the evaluation and classification of potential teratogenicity of industrial poisons].
    Tat-Ha C
    J Toxicol Clin Exp; 1992 May; 12(2):83-95. PubMed ID: 1453349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs.
    Friedman JM
    Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499
    [No Abstract]   [Full Text] [Related]  

  • 57. Obstetric toxicology: teratogens.
    Levine M; O'Connor AD
    Emerg Med Clin North Am; 2012 Nov; 30(4):977-90. PubMed ID: 23137407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methods for detecting teratogenic agents in man.
    Shepard TH; Miller JR
    Environ Health Perspect; 1976 Feb; 13():141-6. PubMed ID: 1269501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinico-teratologic counseling and the Teratology Information Service].
    Stejskal D; Jelínek R; Dostál M
    Ceska Gynekol; 1998 Feb; 63(1):19-22. PubMed ID: 9650376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDA perspectives on the use of teratology data for human risk assessment.
    Frankos VH
    Fundam Appl Toxicol; 1985 Aug; 5(4):615-25. PubMed ID: 3840107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.